Why carry out this study?

Psoriatic disease is the overarching term used to describe the many manifestations of psoriasis, including psoriatic arthritis and the associated systemic comorbidities.

Psoriasis and Beyond: The Global Psoriatic Disease Survey was conducted among patients with moderate to severe plaque psoriasis with/without psoriatic arthritis to assess patients’ understanding of the systemic nature of psoriasis, psoriatic arthritis, and the associated burden of living with these systemic diseases.

What was learned from the study?

The interim results of this study demonstrated that despite many patients having heard the term “psoriatic disease”, the majority of patients were unaware of the systemic nature and increased risk of comorbidities associated with psoriatic disease. Further, psoriatic disease had a substantial negative impact on physical appearance, work, quality of life, emotions, and personal relationships.

On average, the confirmed diagnosis of psoriasis and psoriatic arthritis after first symptom was delayed by 2–3 and 2 years, respectively. Furthermore, many patients with psoriasis were found to be at risk of having psoriatic arthritis.

This interim analysis highlights the need for patient education, productive dialogue, and shared decision-making between patients and healthcare practitioners for optimal management of psoriatic disease.